Leqvio 284 mg/1.5 mL (189 mg/mL) prefilled syringe Images
Generic Name: inclisiran
This medication has been identified as Leqvio 284 mg/1.5 mL (189 mg/mL) prefilled syringe. It is supplied by Novartis Pharmaceuticals Corporation.
Leqvio is used in the treatment of High Cholesterol, Familial Heterozygous; High Cholesterol and belongs to the drug class miscellaneous antihyperlipidemic agents. Leqvio 284 mg/1.5 mL (189 mg/mL) prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Leqvio
- Generic Name
- inclisiran
- Strength
- 284 mg/1.5 mL (189 mg/mL) prefilled syringe
- Availability
- Prescription only
- Drug Class
- Miscellaneous antihyperlipidemic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-1000
More about Leqvio (inclisiran)
- Compare alternatives
- Pricing & coupons
- Reviews (80)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: miscellaneous antihyperlipidemic agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.